Frontlight ResearchEarly access
Trial site
Meditsinski Tsentar Sanador M EOOD
- 3closed trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Rheumatoid arthritis2 trials
- Chronic spontaneous urticaria1 trial
- Phase
- Phase 33 trials
- Status
- Completed3 trials
- Lead sponsor
- Alfasigma S.p.A.1 trial
- Curateq Biologics Private Limited1 trial
- Mabxience Research S.L.1 trial
Closed trials
Completed
Completed
BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026